Measuring, Managing and Monitoring Clinical and Operational Performance

Executive Dialogue

Data Analytics

Transforming health care from a volume-based system that treats disease to a value-based system focused on population health and wellness requires access to real-time patient data. Data analytics is reshaping care delivery, enhancing efficiency and improving outcomes. Risk stratification and predictive analytics capabilities can help clinicians develop tailored interventions, enabling hospitals and health systems to enhance the health of the communities they serve. This executive dialogue explores the biggest opportunities and pain points organizations have encountered with analytics. It also examines what measures hospitals are using to monitor clinical and operational performance, and what hospitals and health systems can do to sustain their results. Use of data for population health management is hampered by the lack of interoperability among providers across the care continuum. Web-based platforms and other information technology solutions are enabling secured data exchange and analytics across multiple sites. Sorting through vast quantities of data in a timely, accurate manner remains a challenge for many hospitals and health systems. When it comes to data analytics, it’s important to start small and build on successes and capabilities.

Sponsored by:

3M Logo

Related Resources

Webinar Recordings
Member
Your browser does not support the video tag.
Guides/Reports
Introduction America’s hospitals and health systems have stepped up in heroic and unprecedented ways to meet the challenges of COVID-19. As outbreaks have…
Advisory
Public
The United States Pharmacopeia (USP) in June 2019 released several new and revised pharmacy compounding standards. Specifically, USP published the final…
Letter/Comment
Public
The American Hospital Association's comments on the Medicare Payment Advisory Commission’s (MedPAC) discussions on consolidation within the health care…
Advisory
Member Non-Fed
At Issue: The United States Pharmacopeia (USP) recently finalized revisions to general chapter <797> (Pharmaceutical Compounding and Sterile…
Letter/Comment
Public
AHA’s comments in response to the Federal Trade Commission's request for comments in connection with the Commission's Certificate of Public Advantage ("COPA")…